CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS
CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS
Recruiting · NCT07612774 · Registry updated 2026-10-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS | Arterial Occlusive Diseases, acute coronary syndrome, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, hypercholesterolemia, autosomal dominant, 3, myocardial ischemia, vascular disorder | Recruiting | Phase 4 | 2026-10-07 | NCT07612774 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| West China Hospital | 359 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tangdu Hospital, Air Force Medical University | Xi’an | China | 2 |
| West China Hospital of Sichuan University | Chengdu | China | 68 |